{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:51:40Z","timestamp":1792093900870,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302052"],"award-info":[{"award-number":["82302052"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471842"],"award-info":[{"award-number":["82471842"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.intimp.2026.117543","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:34:41Z","timestamp":1791981281000},"page":"117543","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["TREM2+ lung macrophages and serum soluble TREM2 in anti-MDA5-positive dermatomyositis-associated interstitial lung disease"],"prefix":"10.1016","volume":"190","author":[{"given":"Qiming","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangtengyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2026.117543_bb0005","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41584-023-01054-9","article-title":"Anti-MDA5 antibody-positive dermatomyositis: pathogenesis and clinical progress","volume":"20","author":"Lu","year":"2024","journal-title":"Nat Rev Rheumatol."},{"issue":"9","key":"10.1016\/j.intimp.2026.117543_bb0010","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/rheumatology\/kes102","article-title":"Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis","volume":"51","author":"Gono","year":"2012","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.intimp.2026.117543_bb0015","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/joim.13607","article-title":"Peripheral lymphocyte count defines the clinical phenotypes and prognosis in patients with anti-MDA5-positive dermatomyositis","volume":"293","author":"Jin","year":"2023","journal-title":"J. Intern. Med."},{"issue":"2","key":"10.1016\/j.intimp.2026.117543_bb0020","doi-asserted-by":"crossref","first-page":"292","DOI":"10.55563\/clinexprheumatol\/zmn18h","article-title":"Serum Krebs von den Lungen-6 concentrations reflect severity of anti-melanoma differentiation-associated protein 5 antibody positive dermatomyositis associated interstitial lung disease","volume":"40","author":"Zhu","year":"2022","journal-title":"Clin. Exp. Rheumatol."},{"issue":"8","key":"10.1016\/j.intimp.2026.117543_bb0025","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22978","article-title":"Serum KL-6 level is a prognostic marker in patients with anti-MDA5 antibody-positive dermatomyositis associated with interstitial lung disease","volume":"33","author":"Ye","year":"2019","journal-title":"J. Clin. Lab Anal."},{"issue":"6","key":"10.1016\/j.intimp.2026.117543_bb0030","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.cell.2020.05.003","article-title":"The physiology, pathology, and potential therapeutic applications of the TREM2 signaling pathway","volume":"181","author":"Deczkowska","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.intimp.2026.117543_bb0035","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1038\/s41467-025-57024-0","article-title":"TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity","volume":"16","author":"Cui","year":"2025","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.intimp.2026.117543_bb0040","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1038\/s41591-023-02327-2","article-title":"An integrated cell atlas of the lung in health and disease","volume":"29","author":"Sikkema","year":"2023","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.117543_bb0045","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00646-2019","article-title":"A spatially restricted fibrotic niche in pulmonary fibrosis is sustained by M-CSF\/M-CSFR signalling in monocyte-derived alveolar macrophages","volume":"55","author":"Joshi","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.intimp.2026.117543_bb0050","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.neulet.2017.09.034","article-title":"ADAM17 is the main sheddase for the generation of human triggering receptor expressed in myeloid cells (hTREM2) ectodomain and cleaves TREM2 after Histidine 157","volume":"660","author":"Feuerbach","year":"2017","journal-title":"Neurosci. Lett."},{"issue":"9","key":"10.1016\/j.intimp.2026.117543_bb0055","first-page":"1582","article-title":"A novel nomogram based on the identification of sTREM2 as a biomarker to predict developing neuropsychiatric systemic lupus erythematosus in lupus patients","volume":"43","author":"Wang","year":"2025","journal-title":"Clin. Exp. Rheumatol."},{"issue":"5","key":"10.1016\/j.intimp.2026.117543_bb0060","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jhep.2022.06.004","article-title":"Soluble TREM2 levels reflect the recruitment and expansion of TREM2(+) macrophages that localize to fibrotic areas and limit NASH","volume":"77","author":"Hendrikx","year":"2022","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117543_bb0065","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.nmd.2019.10.005","article-title":"239th ENMC international workshop: classification of dermatomyositis, Amsterdam, the Netherlands, 14-16 December 2018","volume":"30","author":"Mammen","year":"2020","journal-title":"Neuromuscul. Disord."},{"issue":"10","key":"10.1016\/j.intimp.2026.117543_bb0070","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1093\/rheumatology\/keaa034","article-title":"Clinical significance of radiological patterns of HRCT and their association with macrophage activation in dermatomyositis","volume":"59","author":"Zuo","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.intimp.2026.117543_bb0075","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s10067-019-04457-w","article-title":"Serum YKL-40 level is associated with severity of interstitial lung disease and poor prognosis in dermatomyositis with anti-MDA5 antibody","volume":"38","author":"Jiang","year":"2019","journal-title":"Clin. Rheumatol."},{"issue":"6","key":"10.1016\/j.intimp.2026.117543_bb0080","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1378\/chest.10-0180","article-title":"Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?","volume":"138","author":"Connors","year":"2010","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.intimp.2026.117543_bb0085","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s10020-024-01047-8","article-title":"ADAM Metallopeptidase domain 19 promotes skin fibrosis in systemic sclerosis via neuregulin-1","volume":"30","author":"Meng","year":"2024","journal-title":"Mol. Med."},{"issue":"2","key":"10.1016\/j.intimp.2026.117543_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70226","article-title":"Monocyte-macrophage dynamics as key in disparate lung and peripheral immune responses in severe anti-melanoma differentiation-associated gene 5-positive dermatomyositis-related interstitial lung disease","volume":"15","author":"Shi","year":"2025","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.intimp.2026.117543_bb0095","doi-asserted-by":"crossref","first-page":"1230266","DOI":"10.3389\/fimmu.2023.1230266","article-title":"Dynamic atlas of immune cells reveals multiple functional features of macrophages associated with progression of pulmonary fibrosis","volume":"14","author":"Lv","year":"2023","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2026.117543_bb0100","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1161\/ATVBAHA.121.315145","article-title":"ADAM17 boosts cholesterol efflux and downstream effects of high-density lipoprotein on inflammatory pathways in macrophages","volume":"41","author":"Kothari","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"Si","key":"10.1016\/j.intimp.2026.117543_bb0105","doi-asserted-by":"crossref","first-page":"Si97","DOI":"10.1093\/rheumatology\/keae313","article-title":"Serum interleukin-34 levels in dermatomyositis: a potential biomarker for anti-MDA5-antibody-associated interstitial lung disease","volume":"64","author":"Kuzumi","year":"2025","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.intimp.2026.117543_bb0110","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13075-023-03243-z","article-title":"Proteomic profiling identifies SPP1 associated with rapidly progressive interstitial lung disease in anti-MDA5-positive dermatomyositis","volume":"26","author":"Qiu","year":"2024","journal-title":"Arthritis. Res. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2026.117543_bb0115","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1038\/s41467-020-15647-5","article-title":"Collagen-producing lung cell atlas identifies multiple subsets with distinct localization and relevance to fibrosis","volume":"11","author":"Tsukui","year":"2020","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.intimp.2026.117543_bb0120","doi-asserted-by":"crossref","first-page":"L1046","DOI":"10.1152\/ajplung.00139.2012","article-title":"Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis","volume":"303","author":"Naik","year":"2012","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.intimp.2026.117543_bb0125","doi-asserted-by":"crossref","first-page":"1749098","DOI":"10.3389\/fimmu.2026.1749098","article-title":"The pro-fibrogenic role of SPP1(+) macrophages in medical implant fibrosis: mechanisms and therapeutic opportunities","volume":"17","author":"Yu","year":"2026","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117543_bb0130","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02441-2018","article-title":"Proliferating SPP1\/MERTK-expressing macrophages in idiopathic pulmonary fibrosis","volume":"54","author":"Morse","year":"2019","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.intimp.2026.117543_bb0135","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.chest.2020.04.057","article-title":"Mortality risk prediction in amyopathic dermatomyositis associated with interstitial lung disease: the FLAIR model","volume":"158","author":"Lian","year":"2020","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.intimp.2026.117543_bb0140","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s10067-024-07298-4","article-title":"Clinical features and prognosis of anti-MDA5-positive dermatomyositis with coexistent anti-aminoacyl-tRNA synthetase antibodies","volume":"44","author":"Wang","year":"2025","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.intimp.2026.117543_bb0145","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.molimm.2022.04.003","article-title":"IL-6 regulates induction of C-reactive protein gene expression by activating STAT3 isoforms","volume":"146","author":"Ngwa","year":"2022","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.intimp.2026.117543_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2023.152231","article-title":"Risk factors for mortality in patients with anti-MDA5 antibody-positive dermatomyositis: A meta-analysis and systematic review","volume":"62","author":"Xie","year":"2023","journal-title":"Semin. Arthritis Rheum."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926013913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926013913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:41:07Z","timestamp":1792093267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926013913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":30,"alternative-id":["S1567576926013913"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117543","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TREM2+ lung macrophages and serum soluble TREM2 in anti-MDA5-positive dermatomyositis-associated interstitial lung disease","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117543","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117543"}}